CAMLICA II HEPP

Integrity

The validation report confirms additionality through an investment test, which is a meaningful positive. On the other hand, the verification report says leakage was not addressed, while the monitoring report later describes it as negligible, so I privilege the more recent monitoring statement for operational practice but still discount the score because the inconsistency weakens reliability. Reversal risk is also not clearly treated, with no buffer pool information found and reversal events not clearly addressed in the extracted record.

Transparency

The project has a named verifier, Re Carbon Ltd., and a clear 2023 monitoring period, which supports basic traceability. However, the extracted record does not state the verified or claimed emission reduction totals, and the number of corrective and clarification requests in the verification report suggests the MRV package required substantial cleanup. The documentation is therefore usable but not especially transparent.

Claim Safety

The baseline was last reassessed in 2022, which is a positive sign, but the baseline method remains project-based rather than a more standardized approach. Claim safety is weakened by the leakage inconsistency and by the fact that the project is marked CORSIA-eligible while CCP status is not mentioned, leaving some dual-claim uncertainty. I also note that the verification report predates the monitoring period, so I rely more on the later monitoring report for current operational details, but not enough to offset the overall risk.

Documentation

The record draws on several official documents, including the PDD, validation report, verification report, and monitoring report, and extraction confidence is high. Still, the file set includes an unknown document and multiple contradictions, especially on leakage, benefit sharing, additionality framing, and the crediting period. The large number of corrective and clarification requests in verification also indicates that the documentation was not clean or fully settled at first pass.

Overall

Overall, this is a mid-quality file with some solid project-level evidence but several reliability issues. I privilege the more recent monitoring report for leakage treatment and the validation report for additionality, because they are either newer or more directly tied to the relevant claim, but the contradictions still reduce confidence. The score is held down by unclear leakage treatment, incomplete reversal treatment, and the absence of clear verified issuance figures in the extracted record.